DIAN DIAGNOSTICS(SZ:300244) Xin Lang Cai Jing·2026-02-09 02:42Group 1 - The core viewpoint of the news is that Dian Diagnostics has seen a stock price increase of 5.05%, reaching 24.75 yuan per share, with a trading volume of 328 million yuan and a turnover rate of 2.70%, resulting in a total market capitalization of 15.468 billion yuan [1] - Dian Diagnostics, established on September 5, 2001, and listed on July 19, 2011, provides comprehensive medical diagnostic service solutions primarily to various healthcare institutions, including hospitals and health service centers, with its main business revenue composition being 65.34% from channel products and 34.66% from diagnostic services [1] Group 2 - From the perspective of the top ten circulating shareholders, Yongying Fund has one fund among the top shareholders of Dian Diagnostics, while the Medical Device ETF (159883) entered the top ten circulating shareholders in the third quarter, holding 3.0875 million shares, which accounts for 0.62% of the circulating shares, with an estimated floating profit of approximately 3.6741 million yuan [2] - The Medical Device ETF (159883), managed by fund manager Chu Kefa, has a total asset scale of 5.205 billion yuan, with a best fund return of 103.17% and a worst fund return of -30.27% during his tenure of 2 years and 181 days [3]